Pharma bad boy Martin Shkreli is on the streets again

Former pharma executive Martin Shkreli, who became notorious for raising the price of a lifesaving AIDS drug by around 5,000%, has been released early from his seven-year prison term for de

Judge shuts down Servier's argument that NHS should have sto...

A London high court judge ruled this week that the damages paid to the NHS for an anticompetitive action by French pharma company Servier will not be reduced, despite an eyebrow-raising bid

Shkreli's former company pays $40m in price-gouging settleme...

A pharma company formerly led by 'pharma bro' Martin Shkreli has settled a long-running lawsuit with the US federal government over massive price increases for an off-patent drug treatment

Amgen’s Enbrel heads ICER list of unjustified US price rises

US cost effectiveness watchdog ICER found 10 examples of substantial price rises for top-selling medicines in 2019, and concluded that seven of those were not backed by any clinical evidenc

As election year looms, Democrats lever drug pricing bill th...

Corbyn accuses Tories of planning deal to hike drug prices w...

Drug prices have become an issue in the UK’s general election, after Labour leader Jeremy Corbyn accused the Conservatives of planning a shady deal with Donald Trump that would see the NHS